中文版 | English

在结果中检索

KIZ OpenIR

浏览/检索结果: 共15条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer 期刊论文
CANCER RESEARCH, 2024, 卷号: 84, 期号: 14, 页码: 2282-2296
作者:  Xia, J;  Zhang, LX;  Peng, XL;  Tu, JCL;  Li, SQ;  He, XY;  Li, FK;  Qiang, JK;  Dong, HA;  Deng, QD;  Liu, CC;  Xu, JH;  Zhang, R;  Liu, QT;  Hu, GH;  Liu, C;  Jiang, YZ;  Shao, ZM;  Chen, CS;  Liu, SL
Adobe PDF(4501Kb)  |  收藏  |  浏览/下载：860/0  |  提交时间：2024/08/07
FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 卷号: 41, 期号: 1
作者:  Long, YF;  Chong, TT;  Lyu, XM;  Chen, LJ;  Luo, XM;  Faleti, OD;  Deng, SM;  Wang, F;  He, ML;  Qian, ZP;  Zhao, HL;  Zhou, WY;  Guo, X;  Chen, CS;  Li, X
Adobe PDF(3511Kb)  |  收藏  |  浏览/下载：979/0  |  提交时间：2023/04/18
Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway (vol 10, pg 263, 2020) 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 7, 页码: 3364-3368
作者:  Dong, C;  Chen, Y;  Ma, J;  Yang, RX;  Li, HJ;  Liu, R;  You, DY;  Luo, CX;  Li, H;  Yang, SY;  Ke, KB;  Lin, MCM;  Chen, CS
Adobe PDF(2750Kb)  |  收藏  |  浏览/下载：1041/0  |  提交时间：2023/04/18
Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor-Stroma Cross-talk 期刊论文
CANCER RESEARCH, 2022, 卷号: 82, 期号: 11, 页码: 2124-2140
作者:  Wang, H;  Xu, HB;  Chen, W;  Cheng, M;  Zou, L;  Yang, Q;  Chan, CB;  Zhu, H;  Chen, CS;  Nie, JY;  Jiao, BW
Adobe PDF(2995Kb)  |  收藏  |  浏览/下载：1850/0  |  提交时间：2023/04/12
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 卷号: 41, 期号: 1
作者:  Tu, Qiu;  Liu, Xiuyun;  Yao, Xiaoqing;  Li, Ruixue;  Liu, Gaojing;  Jiang, Honglv;  Li, Kaiqin;  Chen, Qiongfang;  Huang, Xiaoyan;  Chang, Qing;  Xu, Guoqiang;  Zhu, Hong;  Shi, Peng;  Zhao, Bo
Adobe PDF(5144Kb)  |  收藏  |  浏览/下载：3640/4  |  提交时间：2023/02/08
Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 卷号: 10, 期号: 1, 页码: 263-274
作者:  Dong, Chao;  Chen, Yin;  Ma, Jing;  Yang, Runxiang;  Li, Hongjian;  Liu, Rong;  You, Dingyun;  Luo, Chunxiang;  Li, Heng;  Yang, Siyuan;  Ke, Kunbin;  Lin, Marie Chia-mi;  Chen, Ceshi
Adobe PDF(2643Kb)  |  收藏  |  浏览/下载：256/0  |  提交时间：2021/11/11
Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression 期刊论文
CANCER RESEARCH, 2019, 卷号: 79, 期号: 17, 页码: 4399-4411
作者:  He, LL;  Yuan, L;  Sun, Y;  Wang, PY;  Zhang, HL;  Feng, X;  Wang, ZY;  Zhang, WX;  Yang, CY;  Zeng, YA;  Zhao, Y;  Chen, CS;  Zhang, L
Adobe PDF(4258Kb)  |  收藏  |  浏览/下载：180/0  |  提交时间：2021/11/18
Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells 期刊论文
CANCER IMMUNOLOGY RESEARCH, 2019, 卷号: 7, 期号: 11, 页码: 1813-1823
作者:  Sun, B;  Yang, D;  Dai, HJ;  Liu, XY;  Jia, R;  Cui, XY;  Li, WX;  Cai, CC;  Xu, JM;  Zhao, XD
Adobe PDF(1770Kb)  |  收藏  |  浏览/下载：2102/0  |  提交时间：2023/04/12
Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1 期刊论文
Cancer Research, 2019, 卷号: 79, 期号: 1, 页码: 86-99
作者:  Ying Xiang;  Kai Yan;  Qian Zheng;  Haiqiang Ke;  Jie Cheng;  Wenjun Xiong;  Xin Shi;  Lei Wei;  Min Zhao;  Fei Yang;  Ping Wang;  Xing Lu;  Li Fu;  Xuemei Lu;  Feng Li
Adobe PDF(1402Kb)  |  收藏  |  浏览/下载：2246/0  |  提交时间：2023/02/24
RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHK1 inhibitor efficacy in breast cancer cells 期刊论文
Clinical Cancer Research, 2018, 卷号: 24, 期号: 7, 页码: 1629-1643
作者:  Xiaosong Yang;  Junran Zhang;  Zhaojun Qiu;  Zhanwen Du;  Yao Zhang;  Pengyan Fa;  Shashank Gorityala;  Shanhuai Ma;  Shunqiang Li;  Ceshi Chen;  Hongbing Wang;  Yan Xu;  Chunhong Yan;  Keri Ruth;  Zhefu Ma
Adobe PDF(2738Kb)  |  收藏  |  浏览/下载：75/0  |  提交时间：2018/09/28
Rnf126  Chk1  Replication Stress  Breast Cancer  Target Therapy